We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CALL
Insmed
INSM
$27B
| $2.04M | ﹤0.01% |
11,700
-14,200
| -55% | -$2.59M |
|
1802
Solid Biosciences
SLDB
$958M
| $2.04M | ﹤0.01% |
360,937
-371,671
| -51% | -$2.01M |
|
|
UDMY
1803
DELISTED
Udemy
UDMY
| $2.03M | ﹤0.01% |
347,072
+294,653
| +562% | +$1.72M |
|
1804
Kirby Corp
KEX
$7.29B
| $2.02M | ﹤0.01% |
18,365
-91,134
| -83% | -$9.26M |
|
1805
CALL
Root
ROOT
$794M
| $2.02M | ﹤0.01% |
28,000
+6,200
| +28% | +$494K |
|
1806
PUT
Macy's
M
$6.23B
| $2.02M | ﹤0.01% |
91,600
+52,400
| +134% | +$1.07M |
|
1807
Eaton
ETN
$175B
| $2.02M | ﹤0.01% |
6,332
-149,198
| -96% | -$52.9M |
|
1808
Gibraltar Industries
ROCK
$1.43B
| $2.01M | ﹤0.01% |
40,598
+28,740
| +242% | +$1.65M |
|
1809
Under Armour
UAA
$2.31B
| $2M | ﹤0.01% |
403,374
-57,568
| -12% | -$266K |
|
1810
PUT
Starbucks
SBUX
$123B
| $2M | ﹤0.01% |
23,800
-286,200
| -92% | -$24.1M |
|
1811
Invesco Solar ETF
TAN
$1.37B
| $2M | ﹤0.01% |
40,717
+34,526
| +558% | +$1.66M |
|
1812
CALL
M&T Bank
MTB
$36.8B
| $1.99M | ﹤0.01% |
+9,900
| New | +$1.89M |
|
1813
Manulife Financial
MFC
$73.6B
| $1.99M | ﹤0.01% |
+54,957
| New | +$1.87M |
|
1814
Liquidia Corp
LQDA
$6.78B
| $1.99M | ﹤0.01% |
57,670
+47,435
| +463% | +$1.35M |
|
1815
PUT
S&P Global
SPGI
$123B
| $1.99M | ﹤0.01% |
3,800
-3,400
| -47% | -$1.68M |
|
1816
Tradeweb Markets
TW
$22.5B
| $1.98M | ﹤0.01% |
+18,415
| New | +$1.98M |
|
1817
Sabre
SABR
$904M
| $1.98M | ﹤0.01% |
1,455,933
+859,805
| +144% | +$1.48M |
|
1818
CALL
Energy Transfer Partners
ET
$72.2B
| $1.98M | ﹤0.01% |
120,000
| – | – |
|
1819
CALL
DexCom
DXCM
$34.4B
| $1.98M | ﹤0.01% |
29,800
-14,400
| -33% | -$931K |
|
1820
International Money Express
IMXI
$432M
| $1.97M | ﹤0.01% |
128,494
+88,735
| +223% | +$1.33M |
|
1821
Sarepta Therapeutics
SRPT
$1.89B
| $1.97M | ﹤0.01% |
91,619
+38,135
| +71% | +$804K |
|
|
EH
1822
CALL
EHang Holdings
EH
$452M
| $1.97M | ﹤0.01% |
149,300
-98,100
| -40% | -$1.55M |
|
1823
PUT
Dick's Sporting Goods
DKS
$18.1B
| $1.96M | ﹤0.01% |
9,900
-21,900
| -69% | -$4.78M |
|
1824
Zurn Elkay Water Solutions
ZWS
$8.4B
| $1.95M | ﹤0.01% |
42,025
-24,025
| -36% | -$1.13M |
|
1825
ON Semiconductor
ON
$31.9B
| $1.95M | ﹤0.01% |
+35,949
| New | +$1.84M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.